Market Momentum Report: Viking Therapeutics Inc (VKTX)’s Negative Close at 68.48

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Viking Therapeutics Inc (NASDAQ: VKTX) closed at $68.48 in the last session, down -0.54% from day before closing price of $68.85. In other words, the price has decreased by -$0.54 from its previous closing price. On the day, 3.87 million shares were traded. VKTX stock price reached its highest trading level at $70.4 during the session, while it also had its lowest trading level at $65.77.

Ratios:

We take a closer look at VKTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 36.47 and its Current Ratio is at 36.47. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 04, 2024, Reiterated its Buy rating but revised its target price to $102 from $90 previously.

On September 11, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $80.

On June 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $105.Morgan Stanley initiated its Overweight rating on June 27, 2024, with a $105 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 08 ’24 when MACARTNEY LAWSON sold 2,000 shares for $68.67 per share. The transaction valued at 137,333 led to the insider holds 47,965 shares of the business.

LAWSON MACARTNEY bought 2,000 shares of VKTX for $137,333 on Nov 08 ’24. On Oct 28 ’24, another insider, ZANTE GREG, who serves as the Chief Financial Officer of the company, sold 131,687 shares for $76.61 each. As a result, the insider received 10,089,164 and left with 149,366 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 7631137792 and an Enterprise Value of 6701958656.

Stock Price History:

Over the past 52 weeks, VKTX has reached a high of $99.41, while it has fallen to a 52-week low of $9.34. The 50-Day Moving Average of the stock is 5.74%, while the 200-Day Moving Average is calculated to be 12.41%.

Shares Statistics:

According to the various share statistics, VKTX traded on average about 3.86M shares per day over the past 3-months and 7203740 shares per day over the past 10 days. A total of 111.44M shares are outstanding, with a floating share count of 107.93M. Insiders hold about 3.14% of the company’s shares, while institutions hold 74.68% stake in the company. Shares short for VKTX as of 1728950400 were 14393785 with a Short Ratio of 3.73, compared to 1726185600 on 15906671. Therefore, it implies a Short% of Shares Outstanding of 14393785 and a Short% of Float of 17.349999999999998.

Most Popular